Niagen Bioscience says USP publishes monograph for nicotinamide riboside chloride ingredient

Niagen Bioscience Collaborates With Usp to Establish First-Ever Usp Monograph for Nicotinamide Riboside Chloride (Nrcl), the Patented Form in Niagen®

Niagen Bioscience Partners With OneSpaWorld For Cruise Ship Clinics

Niagen announces first cruise ship clinic partnership with OneSpaWorld

Niagen Bioscience Is Maintained at Buy by Canaccord Genuity

Niagen Bioscience Announces First Cruise Ship Clinic Partnership With Onespaworld, Bringing the Nad-Boosting Benefits of Niagen Iv to the High Seas

Niagen Bioscience Doubles Share Repurchase Authorization to $20M

Niagen Bioscience increases share repurchase program to $20M

Niagen Bioscience Increases Share Repurchase Program to $20 Million

Niagen Bioscience to present at the 38th Annual ROTH Conference

Niagen Bioscience tops 300 external research agreements for Niagen and cites 45 published clinical studies

Niagen Bioscience Surpasses 300 External Research Agreements From Leading Global Institutions on Niagen®, Contributing to 45 Published Clinical Studies

Niagen Bioscience launches Niagen Skincare Innovation Lab and debuts Niagen NanoCloud topical product

Niagen Bioscience Is Maintained at Buy by Canaccord Genuity

Niagen Bioscience Inc. Releases Transcript of Fourth Quarter 2025 Earnings Conference Call